Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells

Journal of Infectious Diseases

Volumn 173, Issue 5, 1996, Pages 1164-1170

  Keusch, Gerald T ^a,b   Acheson, David W K ^a   Aaldering, Leonie ^a   Erban, John ^a   Jacewicz, Mary S ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b Tupper Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CYTOKINE; DEXAMETHASONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GLOBOTRIAOSYLCERAMIDE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; VEROTOXIN; VON WILLEBRAND FACTOR;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SAPHENOUS VEIN; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0029953749     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.5.1164     Document Type: Article

References (10)

1. Cleary, TG. Escherichia coli that cause hemolytic uremic syndrome. Infect Dis Clin North Am 1992;6:163-76.
2. Huffman SL. Southwestern internal medicine conference: Shiga-like toxins in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Am J Med Sci 1989;306:398-406.
3. Cleary TG, Lopez EL. The Shiga-like toxin-producing Escherichia coli and hemolytic uremic syndrome. Pediatr Infect Dis J 1989;8:720-4.
4. Obrig TG, Del Vecchio PJ, Brown JE, et al. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun 1988;56:2373-8.
5. Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney L, Daniel TO. Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 1993;268:15484-8.
6. Louise CB, Obrig TG. Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun 1991;59:4173-9.
7. van de Kar NCAJ, Monnens LAH, Karmali MA, van Hinsbergh VWM. Tumor necrosis factor and interleukin-1 induce expression of the verocy-totoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 1992;80:2755-64.
8. McCarthy SA, Kuzu I, Gatter KC, Bicknell R. Heterogeneity of the endothelial cell and its role in organ preference of tumor metastasis. Trends Pharmacol Sci 1991;12:462-7.
9. Goerdt S, Sorg C. Endothelial heterogeneity and the acquired immunodeficiency syndrome: a paradigm for the pathogenesis of vascular disorders. Clin Invest 1992;70:89-98.
10. Augustin HG, Kozian DH, Johnson RC. Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. Bioessays 1994;16:901-6.